{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:10:56Z","timestamp":1792426256138,"version":"4.5.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The natural killer (NK) activity of peripheral blood mononuclear cells (PBMCs) is a crucial defense against the onset and spread of cancer. Studies have shown that patients with reduced NK activity are more susceptible to cancer, and NK activity tends to decrease due to cancer-induced immune suppression. Enhancing the natural cytotoxicity of PBMCs remains a significant task in cancer research.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study investigates the potential of urolithin A, a polyphenolic metabolite produced by the gut microbiota, to enhance the natural cytotoxicity of PBMCs in prostate cancer patients and healthy subjects. We investigated the possible role of aryl hydrocarbon receptor (AhR) in this capability of urolithin A. We analyzed the ability of PBMCs preincubated with urolithin A, AhR agonist or antagonist to kill K562 (human chronic myelogenous leukemia) target cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results demonstrate that urolithin A enhances the natural cytotoxicity of PBMCs in a dose-dependent manner. Specifically, at a concentration of 10\u00a0\u03bcM, urolithin A increased the NK activity of PBMCs from prostate cancer patients by an average of 23% (95% CI, 7%\u201338%). In addition, urolithin A modulates the level of cytokine production by PBMCs, decreasing the level of fractalkine, IL-8, and MCP-3. An AhR antagonist (CH223191, 1\u00a0\u03bcM) also increased NK activity, while an AhR agonist (\u03b2-naphthoflavone, 10\u00a0\u03bcM) did not increase NK activity and partially inhibited the urolithin A-induced enhancement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Urolithin A increases the NK activity of PBMCs from patients with prostate cancer and healthy subjects, and the AhR may be involved in this capability of urolithin A.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1503317","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:11:30Z","timestamp":1736403090000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Vladimir","family":"Rogovskii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir V.","family":"Murugin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Vorobyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Sturov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Krasheninnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Prokhorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18691","DOI":"10.1002\/cam4.6484","article-title":"The tryptophan\u2013kynurenine pathway in immunomodulation and cancer metastasis","volume":"12","author":"Basson","year":"2023","journal-title":"Cancer Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ijnp\/pyy071","article-title":"Making sense of pharmacology: inverse agonism and functional selectivity","volume":"21","author":"Berg","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/toxins12040241","article-title":"Talkin\u2019 toxins: from coley's to modern cancer immunotherapy","volume":"12","author":"Carlson","year":"2020","journal-title":"Toxins (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"121661","DOI":"10.2147\/OTT.S194473","article-title":"Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study","volume":"12","author":"Choi","year":"2019","journal-title":"Onco Targets Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-023-02629-w","article-title":"L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis","volume":"42","author":"Cui","year":"2023","journal-title":"J. Exp. and Clin. Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","article-title":"Impact of the natural compound urolithin A on health, disease, and aging","volume":"27","author":"D'amico","year":"2021","journal-title":"Trends Mol. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41467-024-44789-z","article-title":"Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity","volume":"15","author":"Dean","year":"2024","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.cotox.2017.01.006","article-title":"And now for something completely different: diversity in ligand-dependent activation of ah receptor responses","volume":"2","author":"Denison","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.biopha.2009.02.003","article-title":"Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients","volume":"63","author":"Dewan","year":"2009","journal-title":"Biomed. and Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/ijms23052847","article-title":"Challenges of the immunotherapy: perspectives and limitations of the immune checkpoint inhibitor treatment","volume":"23","author":"Dobosz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2101019","DOI":"10.1002\/mnfr.202101019","article-title":"Urolithins: a comprehensive update on their metabolism, bioactivity, and associated gut microbiota","volume":"66","author":"Garcia-Villalba","year":"2022","journal-title":"Mol. Nutr. Food Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"111260","DOI":"10.1016\/j.fct.2020.111260","article-title":"The gut microbiota metabolite urolithin A, but not other relevant urolithins, induces p53-dependent cellular senescence in human colon cancer cells","volume":"139111260","author":"Gimenez-Bastida","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/2767-9764.CRC-24-0022","article-title":"Urolithin-A promotes CD8+ T cell-mediated cancer immunosurveillance via FOXO1 activation","volume":"4","author":"Ginefra","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.3390\/molecules28103978","article-title":"Aryl hydrocarbon receptor as an anticancer target: an overview of ten years odyssey","volume":"28","author":"Hanieh","year":"2023","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/s0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13837842","DOI":"10.3389\/fimmu.2022.837842","article-title":"Human B cells mediate innate anti-cancer cytotoxicity through concurrent engagement of multiple TNF superfamily ligands","volume":"13","author":"Janjic","year":"2022","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56191","DOI":"10.3791\/56191","article-title":"A flow cytometry-based cytotoxicity assay for the assessment of human NK cell activity","volume":"126","author":"Kandarian","year":"2017","journal-title":"J. Vis. Exp."},{"key":"B19","first-page":"158","article-title":"Effect of interferon-alpha on the NK-cells cytotoxicity in patients with frequently recurrent herpes","volume":"34","author":"Karsonova","year":"2013","journal-title":"Immunologiya"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1038\/s41598-021-83005-6","article-title":"Novel TLR 7\/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)","volume":"11","author":"Khanna","year":"2021","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"67152","DOI":"10.1016\/j.intimp.2018.12.020","article-title":"Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity","volume":"67","author":"Kim","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/metabo8040086","article-title":"Urolithin A is a dietary microbiota-derived human aryl hydrocarbon receptor antagonist","volume":"8","author":"Muku","year":"2018","journal-title":"Metabolites"},{"key":"B23","article-title":"Gleason score","volume-title":"StatPearls","author":"Munjal","year":"2024"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1128\/cvi.05084-11","article-title":"Reduced degranulation of NK cells in patients with frequently recurring herpes","volume":"18","author":"Murugin","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"Ran","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1057555","DOI":"10.3389\/fimmu.2022.1057555","article-title":"Aryl hydrocarbon receptor: the master regulator of immune responses in allergic diseases","volume":"131057555","author":"Riaz","year":"2022","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.2174\/1871520622666220201105204","article-title":"Polyphenols as the potential disease-modifying therapy in cancer","volume":"22","author":"Rogovskii","year":"","journal-title":"Anticancer Agents Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2174\/1568009622666220602125343","article-title":"The therapeutic potential of urolithin A for cancer treatment and prevention","volume":"22","author":"Rogovskii","year":"","journal-title":"Curr. Cancer Drug Targets"},{"key":"B29","article-title":"TNM classification","volume-title":"StatPearls","author":"Rosen","year":"2024"},{"key":"B30","doi-asserted-by":"publisher","first-page":"64103227","DOI":"10.1016\/j.ebiom.2021.103227","article-title":"Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor","volume":"64","author":"Shen","year":"2021","journal-title":"EBioMedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e4122","DOI":"10.1371\/journal.pone.0004122","article-title":"Influenza a virus induces an immediate cytotoxic activity in all major subsets of peripheral blood mononuclear cells","volume":"4","author":"Sturlan","year":"2009","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12865-018-0272-x","article-title":"Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function","volume":"20","author":"Tremblay-Mclean","year":"2019","journal-title":"BMC Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"62101578","DOI":"10.1016\/j.canep.2019.101578","article-title":"Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy","volume":"62","author":"Vidal","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"207102","DOI":"10.1016\/j.biochi.2022.10.018","article-title":"A new insight into the aryl hydrocarbon receptor\/cytochrome 450 signaling pathway in MG63, HOS, SAOS2, and U2OS cell lines","volume":"207","author":"Vorontsova","year":"2023","journal-title":"Biochimie"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1038\/s41598-019-44227-x","article-title":"AICD: an integrated anti-inflammatory compounds database for drug discovery","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cotox.2017.01.008","article-title":"The diverse and important contributions of the AHR to cancer and cancer immunity","volume":"2","author":"Wang","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","article-title":"IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00797-0","article-title":"Natural killer cell infiltration in prostate cancers predict improved patient outcomes","author":"Zorko","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1503317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:11:33Z","timestamp":1736403093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1503317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":38,"alternative-id":["10.3389\/fphar.2024.1503317"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1503317","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"article-number":"1503317"}}